Volume 93 Issue 31 | p. 33 | Concentrates
Issue Date: August 3, 2015

Less Is More With Resveratrol

Chemotherapy: Low dose of the red-wine compound reduces intestinal cancer in mice
Department: Science & Technology

The red-wine compound resveratrol has received a lot of attention as a possible therapy to prevent heart disease and cancer with few side effects in patients at high risk for the diseases. Now a new study reports that resveratrol protects against colorectal cancer in mice, but more so at low, not high, doses (Sci. Transl. Med. 2015, DOI: 10.1126/scitranslmed.aaa7619). Karen Brown of the University of Leicester, in England, and colleagues . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society